The publisher's Medical Devices sector report, “Bioabsorbable Stents (BAS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Bioabsorbable Stents (BAS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Bioabsorbable stents are also known as bioreabsorbable or biodegradable coronary stents. The advantage of this stent is that it does not leave any metal body behind and hence, the possibility of late-stent thrombosis and restenosis decreases. Bioabsorbable stents help in better drug delivery compared to metallic stents.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Bioabsorbable stents are also known as bioreabsorbable or biodegradable coronary stents. The advantage of this stent is that it does not leave any metal body behind and hence, the possibility of late-stent thrombosis and restenosis decreases. Bioabsorbable stents help in better drug delivery compared to metallic stents.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Bioabsorbable Stents (BAS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Bioabsorbable Stents (BAS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Bioabsorbable Stents (BAS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Bioabsorbable Stents (BAS) - Pipeline Products under Development by Companies
5 Bioabsorbable Stents (BAS) Companies and Product Overview
6 Bioabsorbable Stents (BAS)- Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Vascular Inc
- Amaranth Medical Inc
- Arterius Ltd
- Biosensors International Group Ltd
- Biosten, LLC
- Biotronik AG
- Biotronik SE & Co KG
- Biotyx Medical (Shenzhen) Co Ltd
- Boston Scientific Corp
- Cardionovum GmbH
- Cordis Corp
- HangZhou HuaAn Biotechnology Co., Ltd.
- Icon Interventional Systems, Inc.
- Japan Stent Technology Co., Ltd.
- Kyoto Medical Planning Co Ltd
- Lifetech Scientific (Shenzhen) Co Ltd
- Manli Cardiology Ltd
- Meril Life Sciences Pvt Ltd
- Micell Technologies Inc
- Michigan Technological University
- MicroPort Scientific Corp
- Minvasys SAS
- MIV Therapeutics Inc
- NanoCoeur, Inc.
- North Carolina State University
- Northwestern University
- OrbusNeich
- Pediastent LLC
- QualiMed Innovative Medizinprodukte GmbH
- REVA Medical Inc
- S3V Vascular Technologies
- Shanghai Bio-heart Biological Technology Co Ltd
- Shanghai Healing Medical Instruments Co Ltd
- Tepha Inc
- Tremedics Medical Devices LLC
- UAB Minority Health and Health Equity Research Center
- University of Florida
- University of Strathclyde
- VasoTech Inc.
- Xenogenics Corporation
